Who owns RTI Biologics?

Key details on RTI Biologics (Ticker: RTIX)

Who owns RTI Biologics?

Is RTIX a good stock to own? Find out who bought RTI Biologics, who sold RTI Biologics (RTIX) stock, and who holds a large position in RTI Biologics.

Fund Name Number of Shares Share Valuation As Of
Paradigm Capital Management 4.44M $17.62M Dec. 31, 2015
DIMENSIONAL FUND ADVISORS 3.60M $14.27M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 3.36M $13.34M Dec. 31, 2015
HILLMAN 2.68M $10.65M Dec. 31, 2015
KOPP FUNDS 2.17M $7.67M Dec. 31, 2013
First Light Asset Management 2.00M $11.34M Sept. 30, 2015
Vanguard 1.95M $7.76M Dec. 31, 2015
Tamarack Capital Management 1.95M $11.08M Sept. 30, 2015
Rock Springs Capital Management 1.86M $10.56M Sept. 30, 2015
GAGNON SECURITIES 1.84M $9.57M Dec. 31, 2014
Krensavage Asset Management 1.83M $10.39M Sept. 30, 2015
Signia Capital Management 1.68M $7.19M Dec. 31, 2012
Frank Russell Company 1.60M $10.31M June 30, 2015
Fort Washington Investment Advisors 1.58M $5.92M June 30, 2013
Royce & Associates 1.56M $6.19M Dec. 31, 2015
Kopp Investment Advisors 1.56M $10.06M June 30, 2015
BlackRock Fund Advisors 1.53M $7.56M March 31, 2015

Who sold RTI Biologics?

Fund Name Date Sold Number of Shares Sold Share Valuation
STATE STREET CORPORATION Sept. 30, 2011 1.79M $5.88M
Accipiter Capital Management June 30, 2011 1.75M $4.74M
Manulife Asset Management March 31, 2011 1.88M $5.37M
FMR Dec. 31, 2010 8.21M $21.92M